Exclusives

BoStem Technologies announces breakthrough results of BioREtain-processed membranes RE-AC (AmnioWrap2) demonstrating a clear advantage in 12-week DFU healing rates compared to SoC. Results of the study have been published in the recent issue...

Celularity expands its current biomaterial portfolio with the acquisition of Rebound, a full-thickness placental-derived allograft matrix, from Sequence LifeScience. The company expects Rebound sales to contribute revenue in Q424 and fulfill...

SNN announced that the recently launched RENASYS EDGE Negative Pressure Wound Therapy System has won the Red Dot Award for Design Concepts 2024 in the Medical Devices and Technology Category. SNN previously received the same award in 2021 for...

Results of a retro-matched cohort comparing the effectiveness of human keratin matrix (HKM) and SoC in managing full-thickness pressure ulcers found patients treatment with HKM were 2.8 times more likely to experience full wound closure vs...

A national pilot survey of 780 patients with hard-to-heal wounds reported that many delay seeking professional assistance (51% more than 3 months), and only 4% see a wound care specialist. The majority (57%) of patients delayed treatment...

A 25-patient CT will evaluate the safety and performance of MicroMatrix Flex in subjects with wounds complicated by tunneling and/or undermining features with primary outcome of percentage of closure at 12 weeks measured manually. Not yet...

Kerecis announced the publication of the 255-patient Odinn study on grade 2 and 3 DFUs utilizing Marigen (intact fish skin graft). The study found healing was achieved in 44% of patients at 16 weeks vs 26% for SoC, with additional healing at...